Inhibitory effect of herbal remedies on 12-o-tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation

Pharmacological Research

Volumn 45, Issue 3, 2002, Pages 213-220

  Kapadia, Govind J ^a   Azuine, Magnus A ^a   Tokuda, Harukuni ^b   Hang, Eric ^a   Mukainaka, T ^b   Nishino, Hoyoku ^b   Sridhar, Rajagopalan ^a  

^a HOWARD UNIVERSITY   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cancer; Chemoprevention; Epstein Barr virus; Herbs; Medicinal plants

Indexed keywords

ANGELICA EXTRACT; ANTINEOPLASTIC AGENT; BLUEBERRY EXTRACT; CHASTEBERRY EXTRACT; ECHINACEA EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GOLDEN SEAL EXTRACT; HERBACEOUS AGENT; KAVA; LICORICE EXTRACT; MUIRA PUAMA EXTRACT; NETTLE EXTRACT; PASSION FLOWER EXTRACT; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; PYGEUM EXTRACT; SAW PALMETTO EXTRACT; TANACETUM PARTHENIUM EXTRACT; TURMERIC EXTRACT; UNCLASSIFIED DRUG; VALERIAN; VIRUS ANTIGEN; WILD YAM EXTRACT;

ANGELICA; ARTICLE; BLUEBERRY; CANCER CHEMOTHERAPY; CAT CLAW; CHASTEBERRY; CIMICIFUGA RACEMOSA; CONTROLLED STUDY; CURCUMA LONGA; DRUG EFFECT; ECHINACEA; EPSTEIN BARR VIRUS; GINGER; GINKGO BILOBA; GLYCYRRHIZA; GOLDEN SEAL; HOPS; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; MUIRA PUAMA; NETTLE; PASSION FLOWER; PRIORITY JOURNAL; PYGEUM; RAJI CELL; SABAL; TANACETUM PARTHENIUM; YAM;

EID: 0036445937     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0936     Document Type: Article

References (46)

1. Giles JT, Palat CT, Chien SH, Chang ZG, Kennedy DT. Evaluation of Echinacea for treatment of the common cold. Pharmacotherapy 2000; 6: 690-7.
2. Niederau C, Gopfert E. The effect of chelidonium and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study. Medical Klinikum 1999; 94: 425-30.
3. Volz HP, Kiesser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - A randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 1997; 30: 1-5.
4. Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomized multicentre study of treatment for eight weeks. Br Med J 1999; 319: 1534-8.
5. Peters H, Kieser M, Holscher U. Demonstration of the efficacy of Ginkgo biloba special extract EGb 761 on intermittent claudication - A placebo-controlled, double-blind multicenter trial. Vasa 1998; 27: 106-10.
6. Wettstein A. Cholinesterase inhibitors and Gingko extracts - Are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration. Phytomedicine 2000; 6: 393-401.
7. Bhide SV, Azuine MA, Lahiri M, Telang NT. Chemoprevention of mammary tumor virus-induced and chemical carcinogen induced rodent mammary tumors by natural plant products. Breast Cancer Res Tr 1994; 30: 233-42.
8. Kapadia GJ, Tokuda H, Konoshima T, Nishino H. Chemoprevention of lung and skin cancer by Beta vulgaris (beet) root extract. Cancer Lett 1996; 100: 211-4.
9. Kapadia GJ, Balasubramanian V, Tokuda H, Konoshima T, Takasaki M, Koyama J, Tagahaya K, Nishino H. Anti-tumor promoting effects of naphthoquinone derivatives on short term Epstein-Barr early antigen activation assay and in mouse skin carcinogenesis. Cancer Lett 1997; 113: 47-53.
10. Kapadia GJ, Balasubramanian V, Tokuda H, Iwashima A, Nishino H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation by natural colorants. Cancer Lett 1997; 115: 173-8.
11. Kapadia GJ, Tokuda H, Sridar R, Balasubramanian V, Takayasu J, Bu P, Enjo F, Takasaki M, Konoshima T, Nishino H. Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations. Cancer Lett 1998; 129: 87-95.
12. Kapoor LD. Handbook of Ayurvedic Medicinal Plants. Boca Raton, FL: Chemical Rubber Company, 1990.
13. Newall CA, Anderson LA, David Phillipson J. Herbal Medicines. A Guide for Health-Care Professional. London: Pharmaceutical Press, 1996.
14. Azuine MA. Cancer and Ethnobotany of Nigeria. Aachen: Shaker, 1998.
15. Blumenthal M, Busse WR, Goldberg A, Grunewald J, Hall T, Riggins CW, Rister RS. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council, 1998.
16. Foster S, Tyler VE. Tyler's Honest Herbal. A Sensible Guide to the Use of Herbs and Related Remedies. New York: Haworth Herbal, 1999.
17. Blumenthal M, Goldberg A, Brinckman J. Herbal Medicine. Expanded Commission E Monographs. Austin, TX: American Botanical Council, 2000.
18. Ito Y, Yanasse S, Fujita J, Harayama T, Takashima M, Imanaka H. A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus. Cancer Lett 1981; 23: 29-37.
19. Diallo B, Vanhaelen M, Vanhaelen-Fastre R, Konoshima T, Kozuka M, Tokuda H. Studies on inhibitors of skin tumor promotion: Inhibitory effects of triterpenes from Chlosperum tinctorium on Epstein-Barr virus activation. J Nat Prod 1989; 52: 879-81.
20. Takaishi Y, Ujita K, Tokuda H, Nishino H, Iwashima A, Fujita T. Inhibitory effects of dihydroagarofuran sesquiterpenes on Epstein-Barr virus activation. Cancer Lett 1992; 65: 19-26.
21. Furstenberger G, Gross M, Marks F. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandins E and F in conversion (first stage of promotion) and promotion (second stage of tumor promotion). Carcinogenesis 1989; 10: 91-6.
22. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999; 428: 305-27.
23. Hastak K, Lubri N, Jakhi SD, More C, John A, Ghaisas SD, Bhide SV. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett 1997; 116: 265-9.
24. Dorai T, Gehani N, Katz A. Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 2000; 4: 1-6.
25. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L. Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/KK signaling complex. Oncogene 1999; 18: 6013-20.
26. Collett GP, Roobson CN, Mathers JC, Campbell FC. Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumor formation in Apc(min) mice. Carcinogenesis 2001; 22: 821-5.
27. 2+ signaling. Biochem Pharmacol 1999; 58: 1167-72.
28. Yan L, Yee JA, Li D, McGuire MH, Thompson LU. Dietary flaxseed supplementation and experimental metastasis of melanoma cells in cells. Cancer Lett 1998; 124: 181-6.
29. Konrad L, Muller HH, Lenz C, Laubinger H, Aumuller G, Lichius JJ. Antiproliferative effect on human prostate cancer cells by stinging nettle root (Urtica dioica) extract. Planta Medica 2000; 66: 44-7.
30. Agarwal RK, Wang ZY, Muktar H. Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycrrhizin in drinking water. Nutr Cancer 1991; 15: 187-93.
31. Liu XX, Alali FQ, Pilarinou E, McLaughlin JL. Two bioactive mono-tetrahydrofuran acetogenins, annoglacins A and B, from Annona glabra. Phytochemistry 1999; 50: 815-21.
32. Katiyar SK, Agarwal R, Muktar H. Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res 1996; 56: 1023-30.
33. Yasukawa K, Takeuchi M, Takido M. Humulon, a bitter in the hop, inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 1995; 52: 156-8.
34. Shao Y, Ho CT, Chin CK, Badmaev V, Ma W, Huang MT. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Medica 1998; 64: 328-31.
35. Marks LS et al. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol 2000; 163: 1451-6.
36. Romics I, Schmitz H, Frang D. Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year. Int Urol Nephrol 1993; 25: 565-9.
37. Yablonsky F, Niicolas V, Riffaud JP, Bellamy F. Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. J Urol 1997; 157: 2381-7.
38. Chatelain C, Autet W, Brackman F. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: A randomized, double-blind study, with long-term open label extension. Urology 1999; 54: 473-8.
39. Emerit I, Arutyunyan R, Oganesian N, Levy A, Cernjavsky L, Sarkisian T, Pogossian A, Asrian K. Radiation-induced clastogenic factors: Anticlastogenic effect of Ginkgo biloba extract. Free Rad Biol Med 1995; 18: 985-91.
40. Anderson D, Jenkinson PC, Dewdney RS, Blowers SD, Johnson ES, Kadam NP. Chromosomal aberrations and sister chromatid exchanges in lymphocytes and urine mutagenicity of migraine patients: A comparison of chronic feverfew users and matched non-users. Hum Toxicol 1988; 7: 145-52.
41. O'Neill LA, Barrett ML, Lewis GP. Extracts of feverfew inhibit mitogen-induced human peripheral blood mononuclear cell proliferation and cytokine mediated responses: A cytotoxic effect. Br J Clin Pharmacol 1987; 23: 81-3.
42. Sumner H, Salan U, Knight DW, Hoult JR. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components. Biochem Pharmacol 1992; 43: 2313-20.
43. Sheng Y, Pero RW, Ammir A, Bryngelsson C. Induction of apoptosis and inhibition of proliferation in human tumor cells treated with extracts of Uncaria tomentosa. Anticancer Res 1998; 18: 3363-8.
44. T M, a novel aqueous extract from Uncaria tomentosa. J Ethnopharmacol 2000; 69: 115-26.
45. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992; 54: 63-128.
46. Boone CW, Bacus JW, Bacus JV, Steele VE, Kellof GJ. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents. J Cellul Biochem 1997; 28-9 (Suppl.): 1-20.